Abstract
Lowering low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular disease (CVD) morbidity and mortality. Statins are the treatment of choice for lowering LDL-C but a considerable number of patients treated with statins are unable to achieve LDL-C target values and many are statin-intolerant. New LDL-C-lowering drugs--antibodies to PCSK9 (alirocumab, evolocumab and bococizumab)--have been developed and are being tested in large clinical trials. They further reduce LDL-C above maximally tolerated statin therapy by up to > 70%; they also reduce Lp(a), non-HDL-C, apolipoprotein-B, and modestly increase HDL-C. These drugs are well tolerated and even patients who achieved very low LDL-C ≤ 0.65 mmol/l (∼ 25 mg/dl) did not have any significant adverse effects. Treatment with PCSK9 inhibitors resulted in LDL-C target values in 70-90% of patients according to the guidelines. However, although PCSK9 inhibitors seem to be the most promising emerging therapeutic option for LDL-C lowering today, outcome data with endpoints on their effects are still lacking. Another important open question is their long-term safety. Their use in statin-intolerant patients also raises questions, as the criteria for statin-intolerance are neither cle...Continue Reading
References
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Jun 30, 2011·European Heart Journal·UNKNOWN European Association for Cardiovascular Prevention & RehabilitationUNKNOWN ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees
May 29, 2012·Lancet·Evan A SteinRobert Pordy
Jun 6, 2013·Nature Reviews. Cardiology·Željko Reiner
Aug 30, 2013·Croatian Medical Journal·Željko Reiner, Eugenia Tedeschi-Reiner
Nov 26, 2013·Atherosclerosis·Željko ReinerUNKNOWN EUROASPIRE III Study Group
Mar 19, 2014·European Heart Journal·Kausik K RayThomas F Lüscher
Apr 1, 2014·The New England Journal of Medicine·Dirk J BlomUNKNOWN DESCARTES Investigators
Jul 6, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Z Reiner
Oct 6, 2014·Lancet·Frederick J RaalUNKNOWN TESLA Investigators
Oct 15, 2014·Current Pharmaceutical Design·Iveta Simic, Zeljko Reiner
Jan 23, 2015·Postgraduate Medicine·Michael J KorenRobert Dufour
Feb 20, 2015·European Heart Journal·Erik S StroesUNKNOWN European Atherosclerosis Society Consensus Panel
Mar 17, 2015·The New England Journal of Medicine·Jennifer G RobinsonUNKNOWN ODYSSEY LONG TERM Investigators
Mar 17, 2015·The New England Journal of Medicine·Marc S SabatineUNKNOWN Open-Label Study of Long-Term Evaluation against LDL Cholesterol (OSLER) Investigators
Mar 19, 2015·The American Journal of Cardiology·Christie M BallantyneHarold Bays
Apr 29, 2015·Annals of Internal Medicine·Eliano Pio NavareseMalte Kelm
May 7, 2015·Current Opinion in Lipidology·Željko Reiner
Jul 21, 2015·Kardiologia polska·Željko Reiner
Citations
Dec 15, 2015·Expert Review of Proteomics·Alain BeckSarah Cianférani
Jan 27, 2016·Atherosclerosis·Ž ReinerUNKNOWN EUROASPIRE Investigators
Feb 26, 2016·Future Cardiology·Chanukya DahagamSeth S Martin
Jun 30, 2016·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·K YadavK C Ferdinand
Aug 24, 2016·Expert Review of Cardiovascular Therapy·Maria DrakopoulouDimitrios Tousoulis
Oct 14, 2016·Metabolism: Clinical and Experimental·Amirhosssein SahebkarArrigo F G Cicero
Jun 3, 2017·Journal of Cellular Physiology·Farzad KhademiAmirhossein Sahebkar
Jun 24, 2017·European Journal of Preventive Cardiology·Ivan PećinŽeljko Reiner
Jun 7, 2018·European Journal of Preventive Cardiology·Željko Reiner
Jul 7, 2018·Expert Review of Cardiovascular Therapy·Gerald Fitzgerald, Tom Kiernan
Mar 8, 2019·Expert Opinion on Emerging Drugs·Marilisa BoveClaudio Borghi
Mar 30, 2019·European Journal of Preventive Cardiology·Željko Reiner
Jan 25, 2020·Expert Opinion on Drug Discovery·Etienne KhouryDaniel Gaudet
Feb 25, 2020·Critical Reviews in Food Science and Nutrition·Rana ShafabakhshZatollah Asemi
Sep 24, 2020·Expert Opinion on Drug Metabolism & Toxicology·Svetlana MoşteoruMaciej Banach
Oct 23, 2019·Journal of Clinical Medicine·Tannaz JamialahmadiAmirhossein Sahebkar
Mar 18, 2020·European Cardiology·Alberto J Lorenzatti, Peter P Toth
Dec 7, 2018·European Journal of Preventive Cardiology·Ivana VeljićPetar M Seferović
Feb 9, 2019·Medicine·Zonglei ZhaoLixia Wang
Mar 9, 2019·Current Atherosclerosis Reports·Željko Reiner
Jan 3, 2020·Expert Opinion on Pharmacotherapy·Andrea PastaGian Marco Rosa
Apr 25, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Paul S JellingerMichael Davidson
Feb 17, 2021·Biomarkers in Medicine·Elke BouwensIsabella Kardys
Feb 20, 2021·Journal of Experimental Pharmacology·Ivan Pećin, Željko Reiner